PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis (2024)

Abstract

Background & Aims: Acute decompensation (AD) of cirrhosis may present without acute-on-chronic liver failure (ACLF) (AD-No ACLF), or with ACLF (AD-ACLF), defined by organ failure(s). Herein, we aimed to analyze and characterize the precipitants leading to both of these AD phenotypes. Methods: The multicenter, prospective, observational PREDICT study (NCT03056612) included 1,273 non-electively hospitalized patients with AD (No ACLF = 1,071; ACLF = 202). Medical history, clinical data and laboratory data were collected at enrolment and during 90-day follow-up, with particular attention given to the following characteristics of precipitants: induction of organ dysfunction or failure, systemic inflammation, chronology, intensity, and relationship to outcome. Results: Among various clinical events, 4 distinct events were precipitants consistently related to AD: proven bacterial infections, severe alcoholic hepatitis, gastrointestinal bleeding with shock and toxic encephalopathy. Among patients with precipitants in the AD-No ACLF cohort and the AD-ACLF cohort (38% and 71%, respectively), almost all (96% and 97%, respectively) showed proven bacterial infection and severe alcoholic hepatitis, either alone or in combination with other events. Survival was similar in patients with proven bacterial infections or severe alcoholic hepatitis in both AD phenotypes. The number of precipitants was associated with significantly increased 90-day mortality and was paralleled by increasing levels of surrogates for systemic inflammation. Importantly, adequate first-line antibiotic treatment of proven bacterial infections was associated with a lower ACLF development rate and lower 90-day mortality. Conclusions: This study identified precipitants that are significantly associated with a distinct clinical course and prognosis in patients with AD. Specific preventive and therapeutic strategies targeting these events may improve outcomes in patients with decompensated cirrhosis. Lay summary: Acute decompensation (AD) of cirrhosis is characterized by a rapid deterioration in patient health. Herein, we aimed to analyze the precipitating events that cause AD in patients with cirrhosis. Proven bacterial infections and severe alcoholic hepatitis, either alone or in combination, accounted for almost all (96-97%) cases of AD and acute-on-chronic liver failure. Whilst the type of precipitant was not associated with mortality, the number of precipitant(s) was. This study identified precipitants that are significantly associated with a distinct clinical course and prognosis of patients with AD. Specific preventive and therapeutic strategies targeting these events may improve patient outcomes.

Original languageEnglish
JournalJournal of Hepatology
Volume74
Issue number5
Pages (from-to)1097-1108
ISSN0168-8278
DOIs
Publication statusPublished - 2021

Keywords

  • Acute complications
  • Chronic liver disease
  • Non-elective admission
  • Outcome
  • Risk factors

Access to Document

  • PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosisFinal published version, 780 KBLicence: CC BY-NC-ND

    Cite this

    • APA
    • Standard
    • Harvard
    • Vancouver
    • Author
    • BIBTEX
    • RIS

    Trebicka, J., Fernandez, J., Papp, M., Caraceni, P., Laleman, W., Gambino, C., Giovo, I., Uschner, F. E., Jansen, C., Jimenez, C., Mookerjee, R., Gustot, T., Albillos, A., Bañares, R., Jarcuska, P., Steib, C., Reiberger, T., Acevedo, J., Gatti, P., ... PREDICT STUDY group of the EASL-CLIF CONSORTIUM (2021). PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. Journal of Hepatology, 74(5), 1097-1108. https://doi.org/10.1016/j.jhep.2020.11.019

    PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. / Trebicka, Jonel; Fernandez, Javier; Papp, Maria; Caraceni, Paolo; Laleman, Wim; Gambino, Carmine; Giovo, Ilaria; Uschner, Frank Erhard; Jansen, Christian; Jimenez, Cesar; Mookerjee, Rajeshwar; Gustot, Thierry; Albillos, Agustin; Bañares, Rafael; Jarcuska, Peter; Steib, Christian; Reiberger, Thomas; Acevedo, Juan; Gatti, Pietro; Shawcross, Debbie L.; Zeuzem, Stefan; Zipprich, Alexander; Piano, Salvatore; Berg, Thomas; Bruns, Tony; Danielsen, Karen Vagner; Coenraad, Minneke; Merli, Manuela; Stauber, Rudolf; Zoller, Heinz; Ramos, José Presa; Solé, Cristina; Soriano, Germán; de Gottardi, Andrea; Gronbaek, Henning; Saliba, Faouzi; Trautwein, Christian; Kani, Haluk Tarik; Francque, Sven; Ryder, Stephen; Nahon, Pierre; Romero-Gomez, Manuel; Van Vlierberghe, Hans; Francoz, Claire; Manns, Michael; Garcia-Lopez, Elisabet; Tufoni, Manuel; Amoros, Alex; Bendtsen, Flemming; Gluud, Lise Lotte; PREDICT STUDY group of the EASL-CLIF CONSORTIUM.

    In: Journal of Hepatology, Vol. 74, No. 5, 2021, p. 1097-1108.

    Research output: Contribution to journalJournal articleResearchpeer-review

    Trebicka, J, Fernandez, J, Papp, M, Caraceni, P, Laleman, W, Gambino, C, Giovo, I, Uschner, FE, Jansen, C, Jimenez, C, Mookerjee, R, Gustot, T, Albillos, A, Bañares, R, Jarcuska, P, Steib, C, Reiberger, T, Acevedo, J, Gatti, P, Shawcross, DL, Zeuzem, S, Zipprich, A, Piano, S, Berg, T, Bruns, T, Danielsen, KV, Coenraad, M, Merli, M, Stauber, R, Zoller, H, Ramos, JP, Solé, C, Soriano, G, de Gottardi, A, Gronbaek, H, Saliba, F, Trautwein, C, Kani, HT, Francque, S, Ryder, S, Nahon, P, Romero-Gomez, M, Van Vlierberghe, H, Francoz, C, Manns, M, Garcia-Lopez, E, Tufoni, M, Amoros, A, Bendtsen, F, Gluud, LL & PREDICT STUDY group of the EASL-CLIF CONSORTIUM 2021, 'PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis', Journal of Hepatology, vol. 74, no. 5, pp. 1097-1108. https://doi.org/10.1016/j.jhep.2020.11.019

    Trebicka J, Fernandez J, Papp M, Caraceni P, Laleman W, Gambino C et al. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. Journal of Hepatology. 2021;74(5):1097-1108. https://doi.org/10.1016/j.jhep.2020.11.019

    Trebicka, Jonel ; Fernandez, Javier ; Papp, Maria ; Caraceni, Paolo ; Laleman, Wim ; Gambino, Carmine ; Giovo, Ilaria ; Uschner, Frank Erhard ; Jansen, Christian ; Jimenez, Cesar ; Mookerjee, Rajeshwar ; Gustot, Thierry ; Albillos, Agustin ; Bañares, Rafael ; Jarcuska, Peter ; Steib, Christian ; Reiberger, Thomas ; Acevedo, Juan ; Gatti, Pietro ; Shawcross, Debbie L. ; Zeuzem, Stefan ; Zipprich, Alexander ; Piano, Salvatore ; Berg, Thomas ; Bruns, Tony ; Danielsen, Karen Vagner ; Coenraad, Minneke ; Merli, Manuela ; Stauber, Rudolf ; Zoller, Heinz ; Ramos, José Presa ; Solé, Cristina ; Soriano, Germán ; de Gottardi, Andrea ; Gronbaek, Henning ; Saliba, Faouzi ; Trautwein, Christian ; Kani, Haluk Tarik ; Francque, Sven ; Ryder, Stephen ; Nahon, Pierre ; Romero-Gomez, Manuel ; Van Vlierberghe, Hans ; Francoz, Claire ; Manns, Michael ; Garcia-Lopez, Elisabet ; Tufoni, Manuel ; Amoros, Alex ; Bendtsen, Flemming ; Gluud, Lise Lotte ; PREDICT STUDY group of the EASL-CLIF CONSORTIUM. / PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. In: Journal of Hepatology. 2021 ; Vol. 74, No. 5. pp. 1097-1108.

    @article{225a75aab95f426bb9f45a31d3d12402,

    title = "PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis",

    abstract = "Background & Aims: Acute decompensation (AD) of cirrhosis may present without acute-on-chronic liver failure (ACLF) (AD-No ACLF), or with ACLF (AD-ACLF), defined by organ failure(s). Herein, we aimed to analyze and characterize the precipitants leading to both of these AD phenotypes. Methods: The multicenter, prospective, observational PREDICT study (NCT03056612) included 1,273 non-electively hospitalized patients with AD (No ACLF = 1,071; ACLF = 202). Medical history, clinical data and laboratory data were collected at enrolment and during 90-day follow-up, with particular attention given to the following characteristics of precipitants: induction of organ dysfunction or failure, systemic inflammation, chronology, intensity, and relationship to outcome. Results: Among various clinical events, 4 distinct events were precipitants consistently related to AD: proven bacterial infections, severe alcoholic hepatitis, gastrointestinal bleeding with shock and toxic encephalopathy. Among patients with precipitants in the AD-No ACLF cohort and the AD-ACLF cohort (38% and 71%, respectively), almost all (96% and 97%, respectively) showed proven bacterial infection and severe alcoholic hepatitis, either alone or in combination with other events. Survival was similar in patients with proven bacterial infections or severe alcoholic hepatitis in both AD phenotypes. The number of precipitants was associated with significantly increased 90-day mortality and was paralleled by increasing levels of surrogates for systemic inflammation. Importantly, adequate first-line antibiotic treatment of proven bacterial infections was associated with a lower ACLF development rate and lower 90-day mortality. Conclusions: This study identified precipitants that are significantly associated with a distinct clinical course and prognosis in patients with AD. Specific preventive and therapeutic strategies targeting these events may improve outcomes in patients with decompensated cirrhosis. Lay summary: Acute decompensation (AD) of cirrhosis is characterized by a rapid deterioration in patient health. Herein, we aimed to analyze the precipitating events that cause AD in patients with cirrhosis. Proven bacterial infections and severe alcoholic hepatitis, either alone or in combination, accounted for almost all (96-97%) cases of AD and acute-on-chronic liver failure. Whilst the type of precipitant was not associated with mortality, the number of precipitant(s) was. This study identified precipitants that are significantly associated with a distinct clinical course and prognosis of patients with AD. Specific preventive and therapeutic strategies targeting these events may improve patient outcomes.",

    keywords = "Acute complications, Chronic liver disease, Non-elective admission, Outcome, Risk factors",

    author = "Jonel Trebicka and Javier Fernandez and Maria Papp and Paolo Caraceni and Wim Laleman and Carmine Gambino and Ilaria Giovo and Uschner, {Frank Erhard} and Christian Jansen and Cesar Jimenez and Rajeshwar Mookerjee and Thierry Gustot and Agustin Albillos and Rafael Ba{\~n}ares and Peter Jarcuska and Christian Steib and Thomas Reiberger and Juan Acevedo and Pietro Gatti and Shawcross, {Debbie L.} and Stefan Zeuzem and Alexander Zipprich and Salvatore Piano and Thomas Berg and Tony Bruns and Danielsen, {Karen Vagner} and Minneke Coenraad and Manuela Merli and Rudolf Stauber and Heinz Zoller and Ramos, {Jos{\'e} Presa} and Cristina Sol{\'e} and Germ{\'a}n Soriano and {de Gottardi}, Andrea and Henning Gronbaek and Faouzi Saliba and Christian Trautwein and Kani, {Haluk Tarik} and Sven Francque and Stephen Ryder and Pierre Nahon and Manuel Romero-Gomez and {Van Vlierberghe}, Hans and Claire Francoz and Michael Manns and Elisabet Garcia-Lopez and Manuel Tufoni and Alex Amoros and Flemming Bendtsen and Gluud, {Lise Lotte} and {PREDICT STUDY group of the EASL-CLIF CONSORTIUM}",

    year = "2021",

    doi = "10.1016/j.jhep.2020.11.019",

    language = "English",

    volume = "74",

    pages = "1097--1108",

    journal = "Journal of Hepatology, Supplement",

    issn = "0169-5185",

    publisher = "Elsevier",

    number = "5",

    }

    TY - JOUR

    T1 - PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

    AU - Trebicka, Jonel

    AU - Fernandez, Javier

    AU - Papp, Maria

    AU - Caraceni, Paolo

    AU - Laleman, Wim

    AU - Gambino, Carmine

    AU - Giovo, Ilaria

    AU - Uschner, Frank Erhard

    AU - Jansen, Christian

    AU - Jimenez, Cesar

    AU - Mookerjee, Rajeshwar

    AU - Gustot, Thierry

    AU - Albillos, Agustin

    AU - Bañares, Rafael

    AU - Jarcuska, Peter

    AU - Steib, Christian

    AU - Reiberger, Thomas

    AU - Acevedo, Juan

    AU - Gatti, Pietro

    AU - Shawcross, Debbie L.

    AU - Zeuzem, Stefan

    AU - Zipprich, Alexander

    AU - Piano, Salvatore

    AU - Berg, Thomas

    AU - Bruns, Tony

    AU - Danielsen, Karen Vagner

    AU - Coenraad, Minneke

    AU - Merli, Manuela

    AU - Stauber, Rudolf

    AU - Zoller, Heinz

    AU - Ramos, José Presa

    AU - Solé, Cristina

    AU - Soriano, Germán

    AU - de Gottardi, Andrea

    AU - Gronbaek, Henning

    AU - Saliba, Faouzi

    AU - Trautwein, Christian

    AU - Kani, Haluk Tarik

    AU - Francque, Sven

    AU - Ryder, Stephen

    AU - Nahon, Pierre

    AU - Romero-Gomez, Manuel

    AU - Van Vlierberghe, Hans

    AU - Francoz, Claire

    AU - Manns, Michael

    AU - Garcia-Lopez, Elisabet

    AU - Tufoni, Manuel

    AU - Amoros, Alex

    AU - Bendtsen, Flemming

    AU - Gluud, Lise Lotte

    AU - PREDICT STUDY group of the EASL-CLIF CONSORTIUM

    PY - 2021

    Y1 - 2021

    N2 - Background & Aims: Acute decompensation (AD) of cirrhosis may present without acute-on-chronic liver failure (ACLF) (AD-No ACLF), or with ACLF (AD-ACLF), defined by organ failure(s). Herein, we aimed to analyze and characterize the precipitants leading to both of these AD phenotypes. Methods: The multicenter, prospective, observational PREDICT study (NCT03056612) included 1,273 non-electively hospitalized patients with AD (No ACLF = 1,071; ACLF = 202). Medical history, clinical data and laboratory data were collected at enrolment and during 90-day follow-up, with particular attention given to the following characteristics of precipitants: induction of organ dysfunction or failure, systemic inflammation, chronology, intensity, and relationship to outcome. Results: Among various clinical events, 4 distinct events were precipitants consistently related to AD: proven bacterial infections, severe alcoholic hepatitis, gastrointestinal bleeding with shock and toxic encephalopathy. Among patients with precipitants in the AD-No ACLF cohort and the AD-ACLF cohort (38% and 71%, respectively), almost all (96% and 97%, respectively) showed proven bacterial infection and severe alcoholic hepatitis, either alone or in combination with other events. Survival was similar in patients with proven bacterial infections or severe alcoholic hepatitis in both AD phenotypes. The number of precipitants was associated with significantly increased 90-day mortality and was paralleled by increasing levels of surrogates for systemic inflammation. Importantly, adequate first-line antibiotic treatment of proven bacterial infections was associated with a lower ACLF development rate and lower 90-day mortality. Conclusions: This study identified precipitants that are significantly associated with a distinct clinical course and prognosis in patients with AD. Specific preventive and therapeutic strategies targeting these events may improve outcomes in patients with decompensated cirrhosis. Lay summary: Acute decompensation (AD) of cirrhosis is characterized by a rapid deterioration in patient health. Herein, we aimed to analyze the precipitating events that cause AD in patients with cirrhosis. Proven bacterial infections and severe alcoholic hepatitis, either alone or in combination, accounted for almost all (96-97%) cases of AD and acute-on-chronic liver failure. Whilst the type of precipitant was not associated with mortality, the number of precipitant(s) was. This study identified precipitants that are significantly associated with a distinct clinical course and prognosis of patients with AD. Specific preventive and therapeutic strategies targeting these events may improve patient outcomes.

    AB - Background & Aims: Acute decompensation (AD) of cirrhosis may present without acute-on-chronic liver failure (ACLF) (AD-No ACLF), or with ACLF (AD-ACLF), defined by organ failure(s). Herein, we aimed to analyze and characterize the precipitants leading to both of these AD phenotypes. Methods: The multicenter, prospective, observational PREDICT study (NCT03056612) included 1,273 non-electively hospitalized patients with AD (No ACLF = 1,071; ACLF = 202). Medical history, clinical data and laboratory data were collected at enrolment and during 90-day follow-up, with particular attention given to the following characteristics of precipitants: induction of organ dysfunction or failure, systemic inflammation, chronology, intensity, and relationship to outcome. Results: Among various clinical events, 4 distinct events were precipitants consistently related to AD: proven bacterial infections, severe alcoholic hepatitis, gastrointestinal bleeding with shock and toxic encephalopathy. Among patients with precipitants in the AD-No ACLF cohort and the AD-ACLF cohort (38% and 71%, respectively), almost all (96% and 97%, respectively) showed proven bacterial infection and severe alcoholic hepatitis, either alone or in combination with other events. Survival was similar in patients with proven bacterial infections or severe alcoholic hepatitis in both AD phenotypes. The number of precipitants was associated with significantly increased 90-day mortality and was paralleled by increasing levels of surrogates for systemic inflammation. Importantly, adequate first-line antibiotic treatment of proven bacterial infections was associated with a lower ACLF development rate and lower 90-day mortality. Conclusions: This study identified precipitants that are significantly associated with a distinct clinical course and prognosis in patients with AD. Specific preventive and therapeutic strategies targeting these events may improve outcomes in patients with decompensated cirrhosis. Lay summary: Acute decompensation (AD) of cirrhosis is characterized by a rapid deterioration in patient health. Herein, we aimed to analyze the precipitating events that cause AD in patients with cirrhosis. Proven bacterial infections and severe alcoholic hepatitis, either alone or in combination, accounted for almost all (96-97%) cases of AD and acute-on-chronic liver failure. Whilst the type of precipitant was not associated with mortality, the number of precipitant(s) was. This study identified precipitants that are significantly associated with a distinct clinical course and prognosis of patients with AD. Specific preventive and therapeutic strategies targeting these events may improve patient outcomes.

    KW - Acute complications

    KW - Chronic liver disease

    KW - Non-elective admission

    KW - Outcome

    KW - Risk factors

    U2 - 10.1016/j.jhep.2020.11.019

    DO - 10.1016/j.jhep.2020.11.019

    M3 - Journal article

    C2 - 33227350

    AN - SCOPUS:85101877901

    VL - 74

    SP - 1097

    EP - 1108

    JO - Journal of Hepatology, Supplement

    JF - Journal of Hepatology, Supplement

    SN - 0169-5185

    IS - 5

    ER -

    PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis (2024)

    References

    Top Articles
    Latest Posts
    Recommended Articles
    Article information

    Author: Greg O'Connell

    Last Updated:

    Views: 5229

    Rating: 4.1 / 5 (42 voted)

    Reviews: 81% of readers found this page helpful

    Author information

    Name: Greg O'Connell

    Birthday: 1992-01-10

    Address: Suite 517 2436 Jefferey Pass, Shanitaside, UT 27519

    Phone: +2614651609714

    Job: Education Developer

    Hobby: Cooking, Gambling, Pottery, Shooting, Baseball, Singing, Snowboarding

    Introduction: My name is Greg O'Connell, I am a delightful, colorful, talented, kind, lively, modern, tender person who loves writing and wants to share my knowledge and understanding with you.